Search

everythinglearnresearchcommunity

for

Search:↓

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Injecting platelet-rich plasma is a safe and effective way to treat hair loss.

Androgenetic alopecia may increase the severity of COVID-19.

Botox increased hair count in men with baldness and might work by improving scalp blood flow.

Men can report their own balding patterns well enough for large health studies.

Early-onset male baldness is not linked to insulin resistance, but is significantly associated with metabolic syndrome.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

Platelet-rich plasma therapy is more effective than minoxidil lotion for increasing hair count in men with hair loss, with mild side effects and high satisfaction.

Male pattern hair loss is diagnosed and treated earlier and is milder, possibly due to early puberty.

Ahmad's NPRT system accurately documents and predicts male pattern baldness.

More men have Androgenic Alopecia than women, it's often inherited, and stress can contribute to it.

More men have androgenic alopecia than women, with stress linked to the condition in both genders.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

O'Tar T. Norwood was a key figure in creating a system to classify male baldness and founding hair restoration societies.

Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.

PRP is effective in treating male pattern baldness.

Minoxidil and pyrithione zinc combo most effectively increases hair density.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

Hair transplantation has evolved to refined techniques like FUE and FUT, with Finasteride and Minoxidil as the only other proven treatments for hair loss.

Androgenetic alopecia is linked to a higher risk of metabolic syndrome.

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

The conclusion is that more women in their forties are getting AGA and stress is linked to AGA in both men and women.

A new method helps ensure long-lasting hair transplant results by accurately calculating the donor area.

A man with a new type of male pattern hair loss that affects the back of the head responded well to common hair loss treatments.

PRP with microneedling is more effective than PRP alone for treating hair loss.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.